Video
Dr. Michael Philip O'Leary on potential risks of penile implant surgery
Author(s):
O’Leary discusses safety related to instillation of the Penuma penile enhancement implant.
Video Player is loading.
Michael Philip O’Leary, MD, a professor of surgery at Harvard Medical School, discusses potential risks of surgical implantation Penuma, an FDA-cleared penile enhancement implant. O’Leary is 1 of 10 surgeons in the United States capable of performing this surgery, and he recently performed the first Penuma implant at Brigham and Women's Hospital, part of Harvard Medical School. Penuma is a permanent cosmetic penile implant customized to an individual patient’s anatomy.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
An expert discusses patient counseling in wake of FDA’s labeling changes for testosterone
FDA testosterone labeling changes: How will they affect prescribing?
Landon Trost, MD, on the impact of the FDA labeling changes for testosterone products
How urologists can discuss testosterone labeling changes with patients
John P. Mulhall, MD, shares his reaction to the FDA’s testosterone labeling changes
An expert shares their approach to testosterone therapy in men with hypogonadism
Helen L. Bernie, DO, MPH, on the FDA’s labeling changes for testosterone products
Dayna R. Smerina and Amy M. Pearlman, MD, discuss their research in sexual medicine
Adam Lorentz, MD, on predictions for future advances in robotics
Jeffrey A. Albaugh, PhD, APRN, CUCNS, on editing the second edition of SUNA’s Core Curriculum
Related Content
